The Efficacy and Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC: The Real-world Experience from Turkey


KILIÇKAP S., ÖLMEZ Ö. F., ÇİÇİN İ., DEMİRCİ U., ALAN Ö., ÇABUK D., ...More

ESMO (European Society for Medical Oncology) 2018 Congress, Munich, Germany, 19 - 23 October 2018, vol.29

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • Doi Number: 10.1093/annonc/mdy292.023
  • City: Munich
  • Country: Germany
  • Istanbul Medipol University Affiliated: Yes